AAAAAA

   
Results: 1-8 |
Results: 8
Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
Authors: Sadanaga, N Nagashima, H Mashino, K Tahara, K Yamaguchi, H Ohta, M Fujie, T Tanaka, F Inoue, H Takesako, K Akiyoshi, T Mori, M
Citation: N. Sadanaga et al., Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas, CLIN CANC R, 7(8), 2001, pp. 2277-2284
The chemotactic effect of a dermal papilla cell-derived factor on outer root sheath cells
Authors: Fujie, T Katoh, S Oura, H Urano, Y Arase, S
Citation: T. Fujie et al., The chemotactic effect of a dermal papilla cell-derived factor on outer root sheath cells, J DERMA SCI, 25(3), 2001, pp. 206-212
Flowering phenology, pollination, and fruit set of Cypripedium macranthos var. rebunense, a threatened lady's slipper (Orchidaceae)
Authors: Sugiura, N Fujie, T Inoue, K Kitamura, K
Citation: N. Sugiura et al., Flowering phenology, pollination, and fruit set of Cypripedium macranthos var. rebunense, a threatened lady's slipper (Orchidaceae), J PLANT RES, 114(1114), 2001, pp. 171-178
Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
Authors: Yano, T Tanikawa, S Fujie, T Masutani, M Horie, T
Citation: T. Yano et al., Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer, EUR J CANC, 36(5), 2000, pp. 601-609
A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressivenon-Hodgkin's lymphoma
Authors: Tarumi, T Sawada, K Koizumi, K Takano, H Fukada, Y Nishio, M Fujie, T Ohnishi, K Kohno, M Sato, N Sekiguchi, S Koike, T
Citation: T. Tarumi et al., A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressivenon-Hodgkin's lymphoma, LEUK LYMPH, 34(3-4), 1999, pp. 361-371
Moderate dose-intensive chemotherapy for patients with non-small cell lungcancer: Randomized trial, can it improve survival of patients with good performance status?
Authors: Masutani, M Tsujino, I Fujie, T Yamaguchi, M Miyagi, K Yano, T Takahashi, N Koya, Y Horie, T
Citation: M. Masutani et al., Moderate dose-intensive chemotherapy for patients with non-small cell lungcancer: Randomized trial, can it improve survival of patients with good performance status?, ONCOL REP, 6(5), 1999, pp. 1045-1050
Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide
Authors: Fujie, T Tanaka, F Tahara, K Li, J Tanaka, S Mori, M Ueo, H Takesako, K Akiyoshi, T
Citation: T. Fujie et al., Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide, CANCER IMMU, 48(4), 1999, pp. 189-194
A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes
Authors: Fujie, T Tahara, K Tanaka, F Mori, M Takesako, K Akiyoshi, T
Citation: T. Fujie et al., A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes, INT J CANC, 80(2), 1999, pp. 169-172
Risultati: 1-8 |